首页> 外国专利> NEW DERIVATIVES OF CONDENSED HETEROCYCLIC SYSTEMS, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE PREPARATION OF MEDICINAL PRODUCTS

NEW DERIVATIVES OF CONDENSED HETEROCYCLIC SYSTEMS, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE PREPARATION OF MEDICINAL PRODUCTS

机译:稠合杂环系统的新衍生物,其制备,包含它们的药物成分及其在制备医药产品中的用途

摘要

4-Amino-chroman (or thiochroman) 8-carboxamide derivatives (I) are new. Novel intermediates are also claimed. (Thio)chromans of formula (I), in racemic or stereoisomeric form, and their salts are new. R1 = (i) -COCH(NH2)CH2SH, (ii) -CH2CH(NH2)CH2SH or (iii) -CH(R11)(R12); R2 = H, alkyl, aralkyl, aryl, alkylcarbonyl, aralkylcarbonyl, arylcarbonyl or heteroarylalkyl; R3 = H, halo, alkyl, aryl or aralkyl; R4 = -CH(R13)(R14); R5 = H or -C(O)-R15; R6-R8, R12 = H, alkyl, aryl or aralkyl; X = O, S, SO or SO2; R11 = heterocyclyl (optionally substituted by one or more of halo, alkyl (optionally mono- or disubstituted by phenyl), alkoxy, alkylthio, cycloalkylalkyl, or aralkyl or heteroarylalkyl (both optionally ring substituted by one or more of halo, alkyl, alkoxy, CN, NO2, amino (optionally substituted by alkylcarbonyl), alkylsulfonyl, polyfluoroalkyl, polyfluoroalkoxy, polyfluoroalkylthio, aryl or heteroaryl (optionally substituted by one or more of halo, alkyl or alkoxy), aralkyl or aryloxy)); R13, R14 = H; or aryl or heteroaryl (both optionally substituted by one or more of halo, alkyl, alkoxy, OH, NO2, NH2, polyfluoroalkoxy or aralkoxy); provided that R13 and R14 are not both H; R15 = OH, alkoxy, amino, aralkylamino, alkylamino or -NHCH(COOR16)(CH2)2SCH3; R16 = H or alkyl. Independent claims are included for the novel intermediates of formula (II) and (XIV); and for the preparation of (I), (II) (or their protected derivatives) and esters of (XIV).
机译:4-氨基苯并二氢吡喃(或硫代苯并二氢吡喃)8-羧酰胺衍生物(I)是新的。还要求保护新型中间体。外消旋或立体异构形式的式(I)的(硫代)苯并二氢吡喃及其盐是新的。 R1 =(i)-COCH(NH2)CH2SH,(ii)-CH2CH(NH2)CH2SH或(iii)-CH(R11)(R12); R2 = H,烷基,芳烷基,芳基,烷基羰基,芳烷基羰基,芳基羰基或杂芳基烷基; R3 = H,卤素,烷基,芳基或芳烷基; R4 = -CH(R13)(R14); R5 = H或-C(O)-R15; R6-R8,R12 = H,烷基,芳基或芳烷基; X = O,S,SO或SO2; R 11 =杂环基(任选地被卤素,烷基(任选地被苯基单或二取代)中的一个或多个取代,烷氧基,烷硫基,环烷基烷基或芳烷基或杂芳基烷基(均被任选地被卤素,烷基,烷氧基中的一个或多个取代的环) CN,NO 2,氨基(任选被烷基羰基取代),烷基磺酰基,多氟烷基,多氟烷氧基,多氟烷硫基,芳基或杂芳基(任选被卤素,烷基或烷氧基中的一个或多个取代,芳烷基或芳氧基)); R13,R14 = H;或芳基或杂芳基(两者均任选地被卤素,烷基,烷氧基,OH,NO 2,NH 2,多氟烷氧基或芳烷氧基中的一个或多个取代);或前提是R13和R14都不都是H; R15 = OH,烷氧基,氨基,芳烷基氨基,烷基氨基或-NHCH(COOR16)(CH2)2SCH3; R 16 = H或烷基。包括式(II)和(XIV)的新型中间体的独立权利要求;用于制备(I),(II)(或其保护的衍生物)和(XIV)的酯。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号